BILIARY CARCINOMA

Clinical trials for BILIARY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BILIARY CARCINOMA trials appear

Sign up with your email to follow new studies for BILIARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat bile duct cancer: targeted pill enters final testing phase

Disease control Ongoing

This study is testing whether TQB3454 tablets can help people with advanced bile duct cancer that has a specific genetic change (IDH1 mutation) and has stopped responding to standard chemotherapy. About 165 participants are randomly assigned to receive either the experimental pil…

Matched conditions: BILIARY CARCINOMA

Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

BILIARY CARCINOMA

Get alerted when new BILIARY CARCINOMA trials appear

New hope for Tough-to-Treat bile duct cancer: targeted pill enters final testing phase